Last reviewed · How we verify

NCT05584358: BABE

Protein Extrusion and Postprandial Amino Acid Handling

Completed NA Last updated 11 January 2024
What this trial tests

NA trial testing Dry protein blend ingestion in Postprandial Plasma Amino Acid Availability in 9 participants. Completed in 31 August 2023.

Timeline
2 February 2022
Primary endpoint
31 August 2023
31 August 2023

Quick facts

Lead sponsorUniversity of Exeter
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingtriple
Primary purposebasic science
Enrollment9
Start date2 February 2022
Primary completion31 August 2023
Estimated completion31 August 2023
Sites2 locations across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Exeter

Who can join

Adults 18 to 40, any sex, with Postprandial Plasma Amino Acid Availability. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The bulk of research that has investigated the effect of dietary protein on muscle tissue in humans has used isolated, minimally processed protein powders. However, the protein that we consume on a daily basis has typically undergone various processing methods, and evidence suggests these can change the way our bodies metabolise the protein. 'Extrusion' is a common processing method that uses high pressure to produce protein containing cereals and meat replacement foods. There is currently no research looking at how extrusion affects the way a protein source is digested and absorbed in humans. This study will compare the availability of ingested protein in the blood in the hours following consumption of an extruded versus a non-extruded source.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. High-Moisture Extrusion of a Dietary Protein Blend Impairs In Vitro Digestion and Delays In Vivo Postprandial Plasma Amino Acid Availability in Humans.
    West S, Monteyne AJ, Whelehan G, Abdelrahman DR, et al · · 2024 · cited 5× · PMID 38797481 · DOI 10.1016/j.tjnut.2024.05.018

Verify or expand the search:

Other University of Exeter trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05584358.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing